(Q34103163)

31 July 2017

1 reference

title

Innate defences against viraemia (English)

1 reference

31 July 2017

Singh IP

1

1 reference

31 July 2017

Baron S

series ordinal

2

1 reference

31 July 2017

publication date

1 November 2000

1 reference

Reviews in Medical Virology

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

395-403

1 reference

Studies on a heat-labile variola virus inhibitor in normal sera. II. Further characterization of the inhibitor and its activity

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Comparison of the Activities in Inhibition of Haemagglutination by Different Togaviruses for Human Serum Lipoproteins and their Constituents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Inactivation of lysis of oncornaviruses by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

The role of tumor necrosis factor in viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Recently described innate broad spectrum virus inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

A host defense role for a natural antiviral substance in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Protection of mice against Asian influenza-virus infection by a normal horse-serum inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Lipoproteins account for part of the broad non-specific antiviral activity of human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Human Coronavirus OC43 Serum Inhibitor and Neutralizing Antibody by a New Plaque-Reduction Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Vertebrate brains contain a broadly active antiviral substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Factors of natural resistance and specific immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

A QUANTITATIVE ASSAY OF THE IN VIVO PROTECTIVE EFFECT OF GAMMA-INHIBITOR AGAINST INHIBITOR-SENSITIVE A2 INFLUENZA VIRUS STRAINS

21 January 2018

1 reference

12 December 2020

Serum inhibitors of myxoviruses

1 reference

12 December 2020

Different sensitivity of hemagglutinating and hemolytic activities of Sendai virus to non-antibody inhibitors

1 reference

12 December 2020

Further characterization of a broad-spectrum antiviral substance in human serum

1 reference

12 December 2020

Effect of D-1 ethionine on some factors of nonspecific resistance to myxoviruses

1 reference

12 December 2020

Inhibitory effect of heparin on herpes simplex virus

1 reference

12 December 2020

The determination and significance of substances neutralizing Newcastle virus in human serum.

1 reference

12 December 2020

[Serum inhibitors in the guines pig and white rat as possible factors of natural resistance of these animals to infection with certain strains of influenza virus.]

1 reference

12 December 2020

Factors which influence inactivation of vesicular stomatitis virus by fresh human serum

1 reference

12 December 2020

On the therapeutic effect of gamma-inhibitor in mice infected with an inhibitor-sensitive, unadapted A2 influenza virus

1 reference

12 December 2020

Non-specific viral inactivating substance (VIS) in human and mammalian sera; natural antagonists to the inactivator of Newcastle disease virus and observations on the nature of the union between the inactivator and virus

1 reference

12 December 2020

Broadly active inhibitor of viruses spontaneously produced by many cell types in culture

1 reference

12 December 2020

Serum and tissue inhibitors of virus

1 reference

12 December 2020

10.1002/1099-1654(200011/12)10:6<395::AID-RMV298>3.0.CO;2-V

Identifiers

DOI

1 reference

release_sw2xmampvjeqfdtguflztsaisi

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sw2xmampvjeqfdtguflztsaisi

24 November 2022

mapped directly with Wikidata item

1 reference